+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multicancer Screening Market by Test Type (Gene Panel, Laboratory Developed Test, Liquid Biopsy), Cancer Type (Breast Cancer, Colorectal Cancer, Leukemia), Technology, Payment Source, Application, End User - Global Forecast 2025-2030- Product Image
Multicancer Screening Market by Test Type (Gene Panel, Laboratory Developed Test, Liquid Biopsy), Cancer Type (Breast Cancer, Colorectal Cancer, Leukemia), Technology, Payment Source, Application, End User - Global Forecast 2025-2030- Product Image
Sale

Multicancer Screening Market by Test Type (Gene Panel, Laboratory Developed Test, Liquid Biopsy), Cancer Type (Breast Cancer, Colorectal Cancer, Leukemia), Technology, Payment Source, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925117
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The multicancer screening market is poised for accelerated transformation, driven by advancements in molecular diagnostics, regulatory support, and a rising imperative for early detection strategies among diverse patient groups. Senior decision-makers seeking an edge in oncology solutions will benefit from deep insights into technological, regional, and policy-led dynamics shaping this high-opportunity sector.

Market Snapshot: Multicancer Screening Market Growth Trajectory

The Multicancer Screening Market grew from USD 1.53 billion in 2024 to USD 1.67 billion in 2025. It is expected to continue growing at a CAGR of 10.05%, reaching USD 2.72 billion by 2030. This trajectory is underpinned by the adoption of integrated biomarker technologies, increasing collaboration between industry leaders, and shifting payer incentives that support scaling of early detection at population levels.

Scope & Segmentation of the Multicancer Screening Market

  • Test Types: Includes gene panel assays, laboratory developed tests, and liquid biopsy technologies supporting simultaneous or targeted screening approaches.
  • Cancer Types: Focus spans breast, colorectal, leukemia, lung, prostate, and non-specific multi-organ cancers with differentiated assay applications.
  • Technologies: Covers next-generation sequencing, polymerase chain reaction, microarray, and mass spectrometry—each influencing analytical depth and operational efficiency.
  • Payment Sources: Addresses government subsidies, out-of-pocket payment, and private health insurance reflecting public health and private sector reimbursement interests.
  • Applications: Encompasses early diagnostic screening, risk assessment, prognostic monitoring, therapy selection, treatment efficacy assessment, and research for biomarker discovery and genetic evaluation.
  • End Users: Represents ambulatory surgical centers, diagnostic centers, hospitals, research institutions, and specialty clinics serving a range of population cohorts.
  • Regions: Profiled across the Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major EU countries, UAE, Saudi Arabia, South Africa), and Asia-Pacific (China, India, Japan, Australia, among others).

Key Takeaways for Senior Decision-Makers

  • Integrated biomarker screening is expanding the clinical impact of early cancer detection programs, with a shift from single-organ testing toward multi-organ and population-wide strategies.
  • Collaborations between academic, private, and public sector stakeholders are accelerating assay validation, driving innovation across biomarker discovery, next-generation sequencing, and data analytics platforms.
  • Regional investment in healthcare infrastructure and local reagent production is reducing dependency on imports and enabling tailored screening initiatives.
  • Evolving reimbursement models are increasingly linking payments to clinical utility and patient outcomes, supporting the alignment of commercial objectives with healthcare quality goals.
  • Emerging platforms focusing on liquid biopsy and multiplexed panels are reducing per-test costs and reagent consumption, enhancing operational efficiency despite supply chain complexities.
  • New regulatory approvals and policy streamlining are shortening time-to-market for advanced screening assays, with a concurrent rise in public-private partnerships targeting equitable access.

Tariff Impact on Supply Chains and Cost Structures

Recent changes in United States tariff policies have elevated import duties on key laboratory reagents and high-throughput diagnostic instruments. In response, manufacturers are revising sourcing strategies and pursuing domestic supply agreements. Operational adjustments to minimize reagent wastage and boost workflow efficiency are influencing laboratory service pricing. Efforts to secure exemptions and refine tariff classifications are ongoing, with innovators focusing on multiplexed panels and automation to offset rising costs.

Methodology & Data Sources

This report integrates primary and secondary research, expert interviews, quantitative surveys of laboratory and payer stakeholders, and advanced analytics. Multiple peer review rounds and regional modeling ensured robust data integrity and unbiased analysis.

Why This Report Matters to Executive Leadership

  • Supports strategic planning through authoritative market segmentation and actionable insights on technological evolution, reimbursement, and stakeholder collaboration.
  • Arms organizations with a clear understanding of tariff and supply chain shifts, empowering more effective risk management and operational adaptability.
  • Facilitates decision-making for investment, partnership, and go-to-market strategies across diverse regions and end user segments.

Conclusion

The multicancer screening market is redefining early detection and care pathways through converging scientific, commercial, and regulatory shifts. Stakeholders equipped with clear, granular insights are best positioned to seize growth opportunities and enhance patient outcomes in this dynamic field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of AI-driven liquid biopsy assays for early multicancer detection
5.2. Regulatory approval pathways shaping commercialization of next-generation multicancer screening tests
5.3. Rising investment in cfDNA methylation panels enhancing sensitivity and specificity of tests
5.4. Partnerships between diagnostic labs and technology firms accelerating multicancer screening innovation
5.5. Expansion of direct-to-consumer multicancer screening kits enabling at-home sample collection for early diagnosis
5.6. Integration of electronic health records data with screening results to support personalized cancer risk models
5.7. Emergence of value-based reimbursement models influencing adoption of multicancer screening in health systems
5.8. Focus on underserved populations driving development of accessible multicancer detection programs in low-income regions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Multicancer Screening Market, by Test Type
8.1. Introduction
8.2. Gene Panel
8.3. Laboratory Developed Test
8.4. Liquid Biopsy
9. Multicancer Screening Market, by Cancer Type
9.1. Introduction
9.2. Breast Cancer
9.3. Colorectal Cancer
9.4. Leukemia
9.5. Lung Cancer
9.6. Non-Specific Multi-Organ Cancer
9.7. Prostate Cancer
10. Multicancer Screening Market, by Technology
10.1. Introduction
10.2. Mass Spectrometry
10.3. Microarray
10.4. Next - Generation Sequencing
10.5. Polymerase Chain Reaction
11. Multicancer Screening Market, by Payment Source
11.1. Introduction
11.2. Government Subsidies
11.3. Out-of-Pocket Payment
11.4. Private Health Insurance
12. Multicancer Screening Market, by Application
12.1. Introduction
12.2. Diagnostic Screening
12.2.1. Early Detection
12.2.2. Risk Assessment
12.3. Prognostics
12.3.1. Patient Monitoring
12.3.2. Therapy Selection
12.3.3. Treatment Efficacy Assessment
12.4. Research Applications
12.4.1. Biomarker Discovery
12.4.2. Genetic Research
13. Multicancer Screening Market, by End User
13.1. Introduction
13.2. Ambulatory Surgical Centers
13.3. Diagnostic Centers
13.4. Hospitals
13.5. Research Institutions
13.6. Specialty Clinics
14. Americas Multicancer Screening Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Multicancer Screening Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Multicancer Screening Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. ANPAC Bio-Medical Science Co., Ltd.
17.3.2. Burning Rock Biotech Limited
17.3.3. Caris Life Sciences
17.3.4. Coyne Medical Ltd.
17.3.5. Delfi Diagnostics, Inc.
17.3.6. Elypta AB
17.3.7. EpiCypher, Inc.
17.3.8. Epigenomics AG
17.3.9. Exact Sciences Corporation
17.3.10. Foundation Medicine, Inc.
17.3.11. Freenome Holdings, Inc.
17.3.12. Fulgent Genetics, Inc.
17.3.13. Gene Solutions
17.3.14. Grail, LLC by Illumina, Inc.
17.3.15. Guangzhou AnchorDx Medical Co., Ltd.
17.3.16. Guardant Health, Inc.
17.3.17. Invitae Corporation
17.3.18. Laboratory Corporation of America Holdings
17.3.19. Lucence Health Inc.
17.3.20. Micronoma, Inc.
17.3.21. MiRXES Pte Ltd.
17.3.22. Myriad Genetics, Inc.
17.3.23. Natera, Inc.
17.3.24. Naveris, Inc.
17.3.25. NeoGenomics Laboratories
17.3.26. OneTest
17.3.27. Siemens Healthineers AG
17.3.28. StageZero Life Sciences. Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. MULTICANCER SCREENING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MULTICANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. MULTICANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. MULTICANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. MULTICANCER SCREENING MARKET: RESEARCHAI
FIGURE 28. MULTICANCER SCREENING MARKET: RESEARCHSTATISTICS
FIGURE 29. MULTICANCER SCREENING MARKET: RESEARCHCONTACTS
FIGURE 30. MULTICANCER SCREENING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MULTICANCER SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MULTICANCER SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MULTICANCER SCREENING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY GENE PANEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY GENE PANEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY LABORATORY DEVELOPED TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY LABORATORY DEVELOPED TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY NON-SPECIFIC MULTI-ORGAN CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY NON-SPECIFIC MULTI-ORGAN CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY NEXT - GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY NEXT - GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY GOVERNMENT SUBSIDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY GOVERNMENT SUBSIDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY OUT-OF-POCKET PAYMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY OUT-OF-POCKET PAYMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PRIVATE HEALTH INSURANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PRIVATE HEALTH INSURANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY EARLY DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY THERAPY SELECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TREATMENT EFFICACY ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY TREATMENT EFFICACY ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY GENETIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY GENETIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MULTICANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES MULTICANCER SCREENING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 129. CANADA MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 134. CANADA MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 135. CANADA MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 136. CANADA MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 137. CANADA MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. CANADA MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. CANADA MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 140. CANADA MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 141. CANADA MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 142. CANADA MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 143. CANADA MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 144. CANADA MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 145. CANADA MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. CANADA MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 158. MEXICO MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 159. MEXICO MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 162. MEXICO MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 163. MEXICO MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. MEXICO MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MULTICANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. GERMANY MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. GERMANY MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. GERMANY MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. GERMANY MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. GERMANY MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 250. GERMANY MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 251. GERMANY MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 252. GERMANY MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 253. GERMANY MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 254. GERMANY MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 255. GERMANY MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 256. GERMANY MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 257. FRANCE MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. FRANCE MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. FRANCE MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 266. FRANCE MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 267. FRANCE MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 268. FRANCE MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 269. FRANCE MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 270. FRANCE MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 271. FRANCE MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 272. FRANCE MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 273. FRANCE MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. FRANCE MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. ITALY MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 294. ITALY MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 295. ITALY MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 296. ITALY MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 297. ITALY MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. ITALY MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. ITALY MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 300. ITALY MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 301. ITALY MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 302. ITALY MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 303. ITALY MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 304. ITALY MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 305. ITALY MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 306. ITALY MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 307. ITALY MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 308. ITALY MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 309. ITALY MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. ITALY MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. SPAIN MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 314. SPAIN MULTICANCER SCREENING MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 315. SPAIN MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. SPAIN MULTICANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. SPAIN MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2018-2024 (USD MILLION)
TABLE 318. SPAIN MULTICANCER SCREENING MARKET SIZE, BY PAYMENT SOURCE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. SPAIN MULTICANCER SCREENING MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. SPAIN MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2018-2024 (USD MILLION)
TABLE 322. SPAIN MULTICANCER SCREENING MARKET SIZE, BY DIAGNOSTIC SCREENING, 2025-2030 (USD MILLION)
TABLE 323. SPAIN MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2018-2024 (USD MILLION)
TABLE 324. SPAIN MULTICANCER SCREENING MARKET SIZE, BY PROGNOSTICS, 2025-2030 (USD MILLION)
TABLE 325. SPAIN MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 326. SPAIN MULTICANCER SCREENING MARKET SIZE, BY RESEARCH APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 327. SPAIN MULTICANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. SPAIN MULTICANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES MULTICANCER SCREENING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES MULTI

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Multicancer Screening market report include:
  • ANPAC Bio-Medical Science Co., Ltd.
  • Burning Rock Biotech Limited
  • Caris Life Sciences
  • Coyne Medical Ltd.
  • Delfi Diagnostics, Inc.
  • Elypta AB
  • EpiCypher, Inc.
  • Epigenomics AG
  • Exact Sciences Corporation
  • Foundation Medicine, Inc.
  • Freenome Holdings, Inc.
  • Fulgent Genetics, Inc.
  • Gene Solutions
  • Grail, LLC by Illumina, Inc.
  • Guangzhou AnchorDx Medical Co., Ltd.
  • Guardant Health, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Lucence Health Inc.
  • Micronoma, Inc.
  • MiRXES Pte Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Naveris, Inc.
  • NeoGenomics Laboratories
  • OneTest
  • Siemens Healthineers AG
  • StageZero Life Sciences. Ltd.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.67 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.72 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Multicancer Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Multicancer Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 189 Pages
  • Global
From
Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), and Region with Growth Forecasts, 2025-2030 - Product Image

Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report by Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Anemia Diagnostic Solution Market by Product Type (Devices, Reagents, Services), End User (Clinics, Diagnostic Laboratories, Hospitals), Technology, Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Anemia Diagnostic Solution Market by Product Type (Devices, Reagents, Services), End User (Clinics, Diagnostic Laboratories, Hospitals), Technology, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Mens Health Diagnostics Market by Product Type (Imaging Systems, Laboratory Tests), End User (Ambulatory Surgical Centers, Clinics, Diagnostic Centers), Application - Global Forecast 2025-2030 - Product Image

Mens Health Diagnostics Market by Product Type (Imaging Systems, Laboratory Tests), End User (Ambulatory Surgical Centers, Clinics, Diagnostic Centers), Application - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent), By Application (Infectious Disease, Oncology), By End Use (Hospitals & Clinics, Diagnostic Laboratory, Home Care Settings), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent), By Application (Infectious Disease, Oncology), By End Use (Hospitals & Clinics, Diagnostic Laboratory, Home Care Settings), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.